StockComparison Logo
vs

JSPR vs NCEL

Comparison between Jasper Therapeutics Inc (JSPR, Company) and NLS Pharmaceutics Ltd (NCEL, Company).

Both JSPR and NCEL are from the Healthcare sector.

5-Year PerformanceJSPR has outperformed NCEL, delivering a return of -67.8% compared to -68.2%

JSPR vs NCEL - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
JSPR
$17M
Winner
NCEL
$17M
Max Drawdown
Winner
JSPR
99.79%
NCEL
99.92%
Sharpe Ratio
JSPR
-1.10
Winner
NCEL
-0.93
5Y Beta
JSPR
1.47
Winner
NCEL
0.63
Industry
JSPR
Biotechnology
NCEL
Biotechnology
P/E Ratio
JSPR
-0.22
Winner
NCEL
-2.03
Debt to Equity
Winner
JSPR
0.00%
NCEL
4.90%
Free Cash Flow Yield
JSPR
N/A
NCEL
-16.43%
P/B Ratio
JSPR
5.87
Winner
NCEL
2.59

JSPR vs NCEL - Historical Returns

Returns include dividend reinvestment.

1M
Winner
JSPR
+47.46%
NCEL
-8.16%
3M
JSPR
-33.68%
Winner
NCEL
-23.78%
6M
JSPR
-58.05%
Winner
NCEL
+29.28%
1Y
Winner
JSPR
-79.03%
NCEL
-83.28%
5Y(CAGR)
Winner
JSPR
-67.83%
NCEL
-68.24%
Max(CAGR)
JSPR
-67.83%
Winner
NCEL
-65.44%

JSPR vs NCEL - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

YearJSPRNCEL
2026-66.26%+60.83%
2025-91.32%-91.28%
2024+214.13%-91.03%
2023-71.20%-57.86%
2022-93.97%+8.40%
2021-48.08%-61.59%

JSPR vs NCEL Drawdown Comparison

The maximum drawdown for JSPR was -99.79%, occurring on Jun 26, 2026. This drawdown has not yet recovered.

The maximum drawdown for NCEL was -99.92%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The current JSPR drawdown is -99.62%. The current NCEL drawdown is -99.86%.

RankJSPRNCEL
#1-99.79%
Oct 15, 2021 - Jun 26, 2026
-99.92%
Mar 12, 2021 - Mar 30, 2026
#2-52.31%
Sep 24, 2021 - Oct 15, 2021
-35.41%
Feb 11, 2021 - Mar 12, 2021
#3N/A-9.34%
Jan 29, 2021 - Feb 3, 2021
#4N/A-7.69%
Feb 4, 2021 - Feb 11, 2021

Correlation

Correlation between JSPR and NCEL is 0.72 which considered as a strong positive correlation - the stocks tend to move together.

0.72
-101

Select Stocks to Compare